Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

09 Mar 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated March 9, 2022 titled ‘Zydus receives final approval from USFDA for Nitroglycerin Sublingual Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1909.25
Dr. Reddys Labs. 1380.00
Cipla 1401.10
Lupin 2011.35
Zydus Lifesciences 1208.90
View more..